Press release
2025 Nucleic Acid Amplification Testing Market Outlook: Key Indicators Shaping Growth Through 2034
Nucleic Acid Amplification Testing
What Will the Nucleic Acid Amplification Testing Industry Market Size Be by 2025?
There has been a rapid expansion in the size of the nucleic acid amplification testing market in the recent past. The market, which was valued at $9.56 billion in 2024, is projected to reach $11.03 billion in 2025, showing a compound annual growth rate (CAGR) of 15.3%. The historical growth has been influenced by factors such as increased awareness of diagnosis for infectious diseases, identification of new pathogens, the trend towards personalized medicine, demand for point-of-care testing, as well as regulatory approvals and guidelines.
What's the Long-Term Growth Forecast for the Nucleic Acid Amplification Testing Market Size Through 2029?
The market size for nucleic acid amplification testing is predicted to see a significant surge in the coming years, reaching $19.26 billion by 2029, with a CAGR of 15.0%. This anticipated growth over the forecast period could be due to an uptick in infectious diseases, the requirement for large-scale testing capabilities, more investment from private firms, a heightened demand for quick and accurate testing methods, and a surge in advanced diagnostic needs. The forecast period is expected to be marked by several key trends such as artificial intelligence integration, advancements in wearable and implantable devices, increased acceptance in point-of-care testing, growth in personalized medicine, and convergence with digital health technologies.
View the full report here:
https://www.thebusinessresearchcompany.com/report/nucleic-acid-amplification-testing-global-market-report
What Are the Key Growth Drivers Fueling the Nucleic Acid Amplification Testing Market Expansion?
The escalating prevalence of communicable diseases is set to spur the expansion of the nucleic acid amplification testing market in the future. These diseases, which can be spread directly or indirectly via numerous means including physical contact, transmission through the air, unclean food or water, or via insects, are caused by microorganisms. The rise in such diseases is attributable to factors such as resistance to antibiotics, shifting climate conditions, modifications in human behavior, and changes in agricultural methods. Nucleic acid amplification testing (NAAT) aids in the rapid and accurate detection of infectious agents, thereby enabling prompt diagnosis and treatment, which assists in curtailing the proliferation of the diseases. For example, the Public Health Agency of Canada, a government agency based in Canada, disclosed that in the 2022-2023 season, provinces and territories that took part reported 4,216 influenza-related hospitalizations in October 2023. Consequently, the growing prevalence of infectious diseases is prompting the escalation of the nucleic acid amplification testing market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19619&type=smp
What Are the Key Trends Driving Nucleic Acid Amplification Testing Market Growth?
Primary players in the nucleic acid amplification testing market are concentrating their efforts on crafting innovative solutions, including in vitro diagnostics (IVD) assays. These assays are being designed to screen donated blood for CMV using nucleic acid amplification technology (NAT) under the IVDR framework. An IVD assay is a test used on biological specimens to identify diseases, conditions, or infections in a controlled external environment of a lab. To illustrate, GFE, a company based out of Germany, introduced PoET CMV in June 2024. This IVD assay, PoET CMV, is purpose-built for fast and accurate detection of cytomegalovirus (CMV) infections. Distinct features like high sensitivity and specificity make it ideal for early diagnosis and efficient monitoring of CMV in immunocompromised people and individuals receiving transplants. The assay employs state-of-the-art molecular methods to produce dependable results swiftly, thereby aiding immediate clinical decision-making.
How Is the Nucleic Acid Amplification Testing Market Segmented?
The nucleic acid amplification testingmarket covered in this report is segmented -
1) By Type: Target Amplification Systems, Probe Amplification Systems, Signal Amplification Systems
2) By Product Type: Consumables, Instruments Or Systems
3) By Technology: Polymerase Chain Reaction (PCR) Tests, Isothermal Nucleic Acid Amplification Technology (INAAT) Tests, Ligase Chain Reaction (LCR) Tests
4) By Application: Infectious Disease Testing, Oncology Testing, Genetic And Mitochondrial Disease Testing, Other Applications
5) By End-Use: Hospitals, Diagnostic Laboratories, Biotechnology Companies, Other End-Users
Subsegments:
1) By Target Amplification Systems: Polymerase Chain Reaction (PCR), Real-Time PCR (qPCR), Reverse Transcription PCR (RT-PCR), Nested PCR, Multiplex PCR, LAMP (Loop-Mediated Isothermal Amplification),
2) By Probe Amplification Systems: Nucleic Acid Sequence-Based Amplification (NASBA), Hybridization-Based Amplification, Branch Chain Amplification (BCA), Strand Displacement Amplification (SDA),
3) By Signal Amplification Systems: Enzyme-Linked Signal Amplification, Fluorescent Signal Amplification, Chemiluminescent Signal Amplification, Electrochemical Signal Amplification, Magnetic Particle-Based Signal Amplification
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=19619&type=smp
Which Companies Are Leading the Charge in Nucleic Acid Amplification Testing Market Innovation?
Major companies operating in the nucleic acid amplification testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Siemens Healthineers, Becton, Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics, Agilent Technologies Inc., Grifols S.A., Hologic Inc., bioMerieux SA, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., Cepheid Inc., GenScript Biotech Corporation, ARUP Laboratories, BGI Group, Promega Corporation, Meridian Bioscience Inc., Takara Bio Inc., Eiken Chemical Co. Ltd., New England Biolabs Inc., TwistDx Limited, Bioneer Corporation
Which Regions Are Leading the Global Nucleic Acid Amplification Testing Market in Revenue?
North America was the largest region in the nucleic acid amplification testing (NAAT) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nucleic acid amplification testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19619
"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 2025 Nucleic Acid Amplification Testing Market Outlook: Key Indicators Shaping Growth Through 2034 here
News-ID: 4144927 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Amplification
Guest Post: Rolling Circle Amplification Market
Introduction
Rolling Circle Amplification (RCA) is a highly efficient and versatile DNA amplification technique that has gained significant attention in recent years for its potential applications in biotechnology, molecular biology, diagnostics, and nanotechnology. Unlike traditional PCR (Polymerase Chain Reaction), RCA amplifies circular DNA templates through a process where a DNA polymerase synthesizes a long strand of DNA by continuously rolling around the template. This method produces multiple copies of the target…
Rolling Circle Amplification Market: Insights and Trends
Rolling Circle Amplification (RCA) is a novel DNA amplification technique that has gained significant attention in recent years. It is a versatile and efficient method for amplifying circular DNA sequences, and it has found applications in various fields, including molecular diagnostics, biotechnology, and medical research. RCA involves the use of a short DNA primer to initiate the synthesis of long single-stranded DNA products by rolling circle replication. This technique is…
Gene Amplification Technologies Market Size Report 2028
From 2021 to 2028, the global Gene Amplification Technologies Market is predicted to grow at a CAGR of 8.6%, from US$ 26,489 Million in 2020 to US$ 50,636 Million by 2028.
The global gene amplification technologies market is expected to exhibit strong growth during the forecast period, driven by the rising demand for COVID-19 testing and cancer research. This analysis provides comprehensive insights into market size, trends, drivers, challenges, regional outlook,…
Gene Amplification Technologies Market Report 2028
The Gene Amplification Technologies Market Research Report provides an in-depth analysis of the market dynamics, key players, and competitive landscape of the Gene Amplification Technologies industry. It aims to provide valuable insights into the market trends, growth opportunities, and challenges faced by the industry stakeholders. The report serves as a comprehensive guide for businesses and investors looking to make informed decisions in the Gene Amplification Technologies business.
The Gene Amplification Technologies…
Gene Amplification Technologies Market Size, CAGR | Growth - 2028
According to Ameco Research, the worldwide market for gene amplification technologies will increase at a CAGR of more than 8% throughout the forecast period, reaching a market size of more than US$ 50,630 million by 2028.
According to the World Cancer Research Fund, the worldwide toll of cancer cases was more than 18 million in 2020. Out of these, more than 9 million cases were in men and more than…
Whole Genome Amplification Market Investment Analysis
The whole genome amplification market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with the CAGR of 6.90% in the forecast period of 2021 to 2028 and is expected to reach USD 4,492.52 million by 2028. The high application of the method in the various fields of the biological fields is escalating the growth…
